Nathan Ihle

Dr. Ihle will oversee and manage Bolt's manufacturing, process and analytical development, and CMC regulatory strategies. He brings 18 years of CMC strategy and management experience to Bolt.

Dr. Ihle was the founder and Principal at Ihle CMC Solutions. Prior to founding Ihle CMC Solutions, Dr. Ihle was the vice president of manufacturing strategy at Immunomedics, where he developed and implemented the supply strategy and supported the global commercialization of the company's first antibody-drug conjugate product. He was also a key contributor to the company's regulatory submissions. Before working at Immunomedics, Dr. Ihle worked for 16 years at Seattle Genetics as the vice president of CMC strategy and management. At Seattle Genetics, Dr. Ihle was responsible for CMC aspects of development and regulatory strategies for all corporate programs, portfolio and project management and alliance management. Dr. Ihle completed his post-doctoral work as an American Cancer Society Postdoctoral fellow at University of California, Berkeley after receiving his doctorate in Organic Chemistry from Stanford University.